Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-110 of 2297

  • Results filtered:
  • Locations: Jacksonville, FL
Edit search filters
  1. Mononuclear Cells for Biomanufacturing Process Development

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in NMIBC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study of MTI-301 in Patients with Advanced Malignancy

    Jacksonville, FL

  5. Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

    Jacksonville, FL, Rochester, MN

  6. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

    Rochester, MN, Jacksonville, FL

  7. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

    Jacksonville, FL

  8. Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Oligomets pancreas SBRT

    Jacksonville, FL

  10. A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

    Jacksonville, FL, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer